GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)

NSE:GLAXO Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 2, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	473,219	329,173	224,319	281,714	244,012	210,953
Market Cap Growth	18.69%	46.74%	-20.37%	15.45%	15.67%	-4.20%
Enterprise Value	452,258	313,334	211,499	270,099	237,483	201,694
Last Close Price	2797.35	1913.82	1273.47	1509.17	1279.61	1087.91
PE Ratio	55.08	55.80	36.73	16.62	68.13	226.33
PS Ratio	10.30	9.53	6.90	8.59	8.34	6.54
PB Ratio	22.81	18.52	12.88	10.58	16.51	11.59
P/TBV Ratio	23.06	18.77	13.14	10.72	17.01	11.91
P/FCF Ratio	59.76	50.96	36.30	45.72	63.05
P/OCF Ratio	56.56	46.33	34.75	42.22	43.01
EV/Sales Ratio	12.21	9.07	6.50	8.24	8.12	6.26
EV/EBITDA Ratio	41.43	35.58	26.83	36.36	41.42	31.37
EV/EBIT Ratio	43.86	37.35	28.26	38.65	45.71	34.36
EV/FCF Ratio	56.89	48.05	34.80	44.50	60.28
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.02	0.02
Debt / EBITDA Ratio	0.01	0.02	0.02	0.03	0.06	0.06
Debt / FCF Ratio	-	0.03	0.04	0.03	0.07	0.13
Asset Turnover	-	1.00	0.82	0.85	0.94	0.92
Inventory Turnover	-	2.75	2.62	2.55	2.49	2.73
Quick Ratio	-	1.45	1.50	1.83	1.02	1.17
Current Ratio	-	1.84	1.88	2.18	1.63	1.74
Return on Equity (ROE)	-	33.53%	27.59%	18.39%	17.42%	4.71%
Return on Assets (ROA)	-	15.24%	11.75%	11.28%	10.39%	10.42%
Return on Capital (ROIC)	39.68%	29.52%	21.07%	20.82%	19.24%	18.33%
Return on Capital Employed (ROCE)	-	41.30%	37.40%	23.80%	29.50%	27.80%
Earnings Yield	1.82%	1.79%	2.72%	6.02%	1.47%	0.44%
FCF Yield	1.67%	1.96%	2.76%	2.19%	1.59%
Dividend Yield	1.54%	1.67%	2.51%	1.99%	2.34%	1.84%
Payout Ratio	0.00%	91.80%	249.80%	29.89%	189.04%	363.51%
Total Shareholder Return	1.51%	1.67%	2.51%	1.99%	2.34%	1.84%

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.